isoborneol has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, L; Chen, T; He, D; Huang, Y; Yuan, R | 1 |
| Fang, L; Han, S; Li, F; Li, J; Liang, Z; Sun, Y; Tao, C; Xu, X; Zhu, J | 1 |
2 other study(ies) available for isoborneol and Experimental Neoplasms
| Article | Year |
|---|---|
Engineering EHD1-Targeted Natural Borneol Nanoemulsion Potentiates Therapeutic Efficacy of Gefitinib against Nonsmall Lung Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camphanes; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cells, Cultured; Drug Screening Assays, Antitumor; Emulsions; Female; Gefitinib; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Particle Size; Surface Properties; Vesicular Transport Proteins | 2020 |
A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Cell Line; Dendrimers; Doxorubicin; Endothelial Cells; Folic Acid; Glioma; Humans; Molecular Structure; Neoplasms, Experimental; Neuroglia; Rats; Rats, Wistar; Tissue Distribution | 2016 |